BEXAROTENE AUGMENTATION SUPPORTS THE RETINOID DYSREGULATION HYPOTHESIS OF SCHIZOPHRENIA: FINDINGS FROM A 6-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL

被引：0
|
作者：
Lerner, Vladimir [1 ]
Miodownik, Chanoch [1 ]
Sirota, Pinchas [2 ]
Gibel, Anatoly [3 ]
Bush, Ilan [1 ]
Hadi, Elliot [2 ]
Benatov, Ruben [2 ]
Ritsner, Michael S. [3 ]
机构：
[1] Ben Gurion Univ Negev, Fac Hlth Sci, Div Psychiat, Minist Hlth,Mental Hlth Ctr, Beer Sheva, Israel
[2] Abarbanel Mental Hlth Ctr, Bat Yam, Israel
[3] Shaar Menashe Mental Hlth Ctr, Hadera, Israel
来源：
ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES | 2012年 / 49卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：36 / 36
页数：1
相关论文
共 50 条
  • [1] The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial
    Lerner, Vladimir
    Miodownik, Chanoch
    Gibel, Anatoly
    Sirota, Pinchas
    Bush, Ilan
    Elliot, Hadi
    Benatov, Ruben
    Ritsner, Michael S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2013, 74 (12) : 1224 - 1232
  • [2] Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial
    Kryzhanovskaya, Ludmila
    Schulz, S. Charles
    McDougle, Christopher
    Frazier, Jean
    Dittmann, Ralf
    Robertson-Plouch, Carol
    Bauer, Theresa
    Xu, Wen
    Wang, Wei
    Carlson, Janice
    Tohen, Mauricio
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2009, 48 (01): : 60 - 70
  • [3] A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia
    Shen, Joan H. Q.
    Zhao, Yonggang
    Rosenzweig-Lipson, Sharon
    Popp, Danielle
    Williams, Janet B. W.
    Giller, Earl
    Detke, Michael J.
    Kane, John M.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2014, 53 : 14 - 22
  • [4] Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial
    Correll, Christoph U.
    Skuban, Aleksandar
    Ouyang, John
    Hobart, Mary
    Pfister, Stephanie
    McQuade, Robert D.
    Nyilas, Margaretta
    Carson, William H.
    Sanchez, Raymond
    Eriksson, Hans
    AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (09): : 870 - 880
  • [5] A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia
    Haas, Magali
    Unis, Alan S.
    Armenteros, Jorge
    Copenhaver, Margaret D.
    Quiroz, Jorge A.
    Kushner, Stuart F.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (06) : 611 - 621
  • [6] Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study
    Iwata, Nakao
    Ishigooka, Jun
    Kim, Won-Hyoung
    Yoon, Bo-Hyun
    Lin, Shih-Ku
    Sulaiman, Ahmad Hatim
    Cosca, Rowena
    Wang, Lina
    Suchkov, Yury
    Agarkov, Alexey
    Watabe, Kei
    Matsui, Tomohito
    Sato, Takayuki
    Inoue, Yoshifumi
    Higuchi, Teruhiko
    Correll, Christoph U.
    Kane, John M.
    SCHIZOPHRENIA RESEARCH, 2020, 215 : 408 - 415
  • [7] Efficacy and Safety of Quetiapine in Adolescents with Schizophrenia Investigated in a 6-Week, Double-Blind, Placebo-Controlled Trial
    Findling, Robert L.
    McKenna, Kathleen
    Earley, Willie R.
    Stankowski, Jill
    Pathak, Sanjeev
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2012, 22 (05) : 327 - 342
  • [8] Clonidine augmentation in patients with schizophrenia: A double-blind, randomized placebo-controlled trial
    Kruiper, Caitlyn
    Sommer, Iris E. C.
    Koster, Michiel
    Bakker, P. Roberto
    Durston, Sarah
    Oranje, Bob
    SCHIZOPHRENIA RESEARCH, 2023, 255 : 148 - 154
  • [9] THE EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENT PATIENTS WITH SCHIZOPHRENIA: A 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY
    Goldman, Robert S.
    Findling, Robert L.
    Silva, Robert M.
    Cucchiaro, Josephine B.
    Deng, Ling
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S163 - S164
  • [10] The Efficacy and Safety of Lurasidone in Adolescent Patients With Schizophrenia: A 6-Week, Double-Blind, Placebo-Controlled, Multicenter Study
    Correll, Christoph U.
    Goldman, Robert
    Silva, Robert
    Cucchiaro, Josephine
    Deng, Ling
    Loebel, Antony
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S597 - S598
12345